Hence, these results suggest that C. jejuni-induced colitis or colorectal tumorigenesis can be attenuated by inactivation of mTOR signaling using pharmacological interventions such as rapamycin or PI3K-γ inhibitors [62,139]. This evidence concerns the gene MTOR and colitis.